+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Mobile Cardiac Telemetry Devices Market Research Report by Technology (Lead-based Technology and Patch-based Technology), End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5123784
  • Report
  • April 2022
  • Region: United States
  • 107 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • BioTelemetry Inc.
  • Biotricity Inc.
  • Medicomp Inc.
  • Medtronic plc
  • National Cardiac Inc.
  • Telerhythmics LLC
The United States Mobile Cardiac Telemetry Devices Market size was estimated at USD 156.78 million in 2021, USD 185.41 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 14.55% to reach USD 354.39 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Mobile Cardiac Telemetry Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Lead-based Technology and Patch-based Technology.
  • Based on End-User, the market was studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Mobile Cardiac Telemetry Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Mobile Cardiac Telemetry Devices Market, including Applied Cardiac Systems Inc., BioTelemetry Inc., Biotricity Inc., Boston Scientific Corporation, Medicomp Inc., Medtronic plc, National Cardiac Inc., Preventice Solutions, Inc., Telerhythmics LLC, and The ScottCare Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Mobile Cardiac Telemetry Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Mobile Cardiac Telemetry Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Mobile Cardiac Telemetry Devices Market?
4. What is the competitive strategic window for opportunities in the United States Mobile Cardiac Telemetry Devices Market?
5. What are the technology trends and regulatory frameworks in the United States Mobile Cardiac Telemetry Devices Market?
6. What is the market share of the leading vendors in the United States Mobile Cardiac Telemetry Devices Market?
7. What modes and strategic moves are considered suitable for entering the United States Mobile Cardiac Telemetry Devices Market?
Frequently Asked Questions about the U.S. Mobile Cardiac Telemetry Devices Market

What is the estimated value of the U.S. Mobile Cardiac Telemetry Devices Market?

The U.S. Mobile Cardiac Telemetry Devices Market was estimated to be valued at $156.8 Million in 2021.

What is the growth rate of the U.S. Mobile Cardiac Telemetry Devices Market?

The growth rate of the U.S. Mobile Cardiac Telemetry Devices Market is 14.5%, with an estimated value of $354.4 Million by 2027.

What is the forecasted size of the U.S. Mobile Cardiac Telemetry Devices Market?

The U.S. Mobile Cardiac Telemetry Devices Market is estimated to be worth $354.4 Million by 2027.

Who are the key companies in the U.S. Mobile Cardiac Telemetry Devices Market?

Key companies in the U.S. Mobile Cardiac Telemetry Devices Market include Applied Cardiac Systems Inc., BioTelemetry Inc., Biotricity Inc., Boston Scientific Corporation, Medicomp Inc., Medtronic plc, National Cardiac Inc., Preventice Solutions, Inc. and The ScottCare Corporation.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BioTelemetry Inc.
  • Biotricity Inc.
  • Medicomp Inc.
  • Medtronic plc
  • National Cardiac Inc.
  • Telerhythmics LLC

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Mobile Cardiac Telemetry Devices Market, by Technology
6.1. Introduction
6.2. Lead-based Technology
6.3. Patch-based Technology
7. Mobile Cardiac Telemetry Devices Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Clinics
7.4. Hospitals
8. California Mobile Cardiac Telemetry Devices Market9. Florida Mobile Cardiac Telemetry Devices Market10. Illinois Mobile Cardiac Telemetry Devices Market11. New York Mobile Cardiac Telemetry Devices Market12. Ohio Mobile Cardiac Telemetry Devices Market13. Pennsylvania Mobile Cardiac Telemetry Devices Market14. Texas Mobile Cardiac Telemetry Devices Market
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Applied Cardiac Systems Inc.
16.2. BioTelemetry Inc.
16.3. Biotricity Inc.
16.4. Boston Scientific Corporation
16.5. Medicomp Inc.
16.6. Medtronic plc
16.7. National Cardiac Inc.
16.8. Preventice Solutions, Inc.
16.9. Telerhythmics LLC
16.10. The ScottCare Corporation
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: DYNAMICS
FIGURE 2. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 3. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 5. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY LEAD-BASED TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 6. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY LEAD-BASED TECHNOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 7. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY PATCH-BASED TECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 8. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY PATCH-BASED TECHNOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 9. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 10. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY END-USER, 2027
FIGURE 12. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 13. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY CLINICS, 2019-2027 (USD MILLION)
FIGURE 15. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 17. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: FPNV POSITIONING MATRIX
FIGURE 19. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 20. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY LEAD-BASED TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY PATCH-BASED TECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: SCORES
TABLE 11. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: BUSINESS STRATEGY
TABLE 12. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: PRODUCT SATISFACTION
TABLE 13. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: RANKING
TABLE 14. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 15. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: MERGER & ACQUISITION
TABLE 16. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 17. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 18. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: INVESTMENT & FUNDING
TABLE 19. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 20. UNITED STATES MOBILE CARDIAC TELEMETRY DEVICES MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Applied Cardiac Systems Inc.
  • BioTelemetry Inc.
  • Biotricity Inc.
  • Boston Scientific Corporation
  • Medicomp Inc.
  • Medtronic plc
  • National Cardiac Inc.
  • Preventice Solutions, Inc.
  • Telerhythmics LLC
  • The ScottCare Corporation
Note: Product cover images may vary from those shown

Loading
LOADING...